These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 33721566)

  • 1. Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial.
    Thomas R; Probert WJM; Sauter R; Mwenge L; Singh S; Kanema S; Vanqa N; Harper A; Burger R; Cori A; Pickles M; Bell-Mandla N; Yang B; Bwalya J; Phiri M; Shanaube K; Floyd S; Donnell D; Bock P; Ayles H; Fidler S; Hayes RJ; Fraser C; Hauck K;
    Lancet Glob Health; 2021 May; 9(5):e668-e680. PubMed ID: 33721566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa (the HPTN 071 [PopART] trial): a modelling study.
    Probert WJM; Sauter R; Pickles M; Cori A; Bell-Mandla NF; Bwalya J; Abeler-Dörner L; Bock P; Donnell DJ; Floyd S; Macleod D; Piwowar-Manning E; Skalland T; Shanaube K; Wilson E; Yang B; Ayles H; Fidler S; Hayes RJ; Fraser C;
    Lancet HIV; 2022 Nov; 9(11):e771-e780. PubMed ID: 36332654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV testing and treatment coverage achieved after 4 years across 14 urban and peri-urban communities in Zambia and South Africa: An analysis of findings from the HPTN 071 (PopART) trial.
    Floyd S; Shanaube K; Yang B; Schaap A; Griffith S; Phiri M; Macleod D; Sloot R; Sabapathy K; Bond V; Bock P; Ayles H; Fidler S; Hayes R;
    PLoS Med; 2020 Apr; 17(4):e1003067. PubMed ID: 32240156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2: a prespecified secondary outcomes analysis of the HPTN 071 (PopART) community-randomised trial.
    Wilson E; Donnell D; Skalland T; Floyd S; Moore A; Bell-Mandla N; Bwalya J; Kasese N; Dunbar R; Shanaube K; Kosloff B; Laeyendecker O; Agyei Y; Hoddinott G; Bock P; Fidler S; Hayes R; Ayles H;
    Lancet HIV; 2022 Nov; 9(11):e760-e770. PubMed ID: 36332653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysis.
    Macleod D; Shanaube K; Skalland T; Limbada M; Mandla N; Bwalya J; Schaap A; Yang B; Donnell D; Piwowar-Manning E; Eshleman SH; Hoddinott G; Bond V; Moore A; Griffith S; Bock P; Ayles H; Fidler S; Hayes R; Floyd S;
    Lancet HIV; 2022 Nov; 9(11):e751-e759. PubMed ID: 36332652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS).
    Klinkenberg E; Floyd S; Shanaube K; Mureithi L; Gachie T; de Haas P; Kosloff B; Dodd PJ; Ruperez M; Wapamesa C; Burnett JM; Kalisvaart N; Kasese N; Vermaak R; Schaap A; Fidler S; Hayes R; Ayles H;
    PLoS Med; 2023 Sep; 20(9):e1004278. PubMed ID: 37682971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment - a study protocol for a cluster randomised trial.
    Hayes R; Ayles H; Beyers N; Sabapathy K; Floyd S; Shanaube K; Bock P; Griffith S; Moore A; Watson-Jones D; Fraser C; Vermund SH; Fidler S;
    Trials; 2014 Feb; 15():57. PubMed ID: 24524229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.
    Eaton JW; Menzies NA; Stover J; Cambiano V; Chindelevitch L; Cori A; Hontelez JA; Humair S; Kerr CC; Klein DJ; Mishra S; Mitchell KM; Nichols BE; Vickerman P; Bakker R; Bärnighausen T; Bershteyn A; Bloom DE; Boily MC; Chang ST; Cohen T; Dodd PJ; Fraser C; Gopalappa C; Lundgren J; Martin NK; Mikkelsen E; Mountain E; Pham QD; Pickles M; Phillips A; Platt L; Pretorius C; Prudden HJ; Salomon JA; van de Vijver DA; de Vlas SJ; Wagner BG; White RG; Wilson DP; Zhang L; Blandford J; Meyer-Rath G; Remme M; Revill P; Sangrujee N; Terris-Prestholt F; Doherty M; Shaffer N; Easterbrook PJ; Hirnschall G; Hallett TB
    Lancet Glob Health; 2014 Jan; 2(1):e23-34. PubMed ID: 25104632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.
    Hayes R; Floyd S; Schaap A; Shanaube K; Bock P; Sabapathy K; Griffith S; Donnell D; Piwowar-Manning E; El-Sadr W; Beyers N; Ayles H; Fidler S;
    PLoS Med; 2017 May; 14(5):e1002292. PubMed ID: 28464041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial.
    Thomas R; Burger R; Harper A; Kanema S; Mwenge L; Vanqa N; Bell-Mandla N; Smith PC; Floyd S; Bock P; Ayles H; Beyers N; Donnell D; Fidler S; Hayes R; Hauck K;
    Lancet Glob Health; 2017 Nov; 5(11):e1133-e1141. PubMed ID: 28964756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community based distribution of oral HIV self-testing kits in Zambia: a cluster-randomised trial nested in four HPTN 071 (PopART) intervention communities.
    Mulubwa C; Hensen B; Phiri MM; Shanaube K; Schaap AJ; Floyd S; Phiri CR; Bwalya C; Bond V; Simwinga M; Mwenge L; Fidler S; Hayes R; Mwinga A; Ayles H;
    Lancet HIV; 2019 Feb; 6(2):e81-e92. PubMed ID: 30584047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART).
    Hayes RJ; Donnell D; Floyd S; Mandla N; Bwalya J; Sabapathy K; Yang B; Phiri M; Schaap A; Eshleman SH; Piwowar-Manning E; Kosloff B; James A; Skalland T; Wilson E; Emel L; Macleod D; Dunbar R; Simwinga M; Makola N; Bond V; Hoddinott G; Moore A; Griffith S; Deshmane Sista N; Vermund SH; El-Sadr W; Burns DN; Hargreaves JR; Hauck K; Fraser C; Shanaube K; Bock P; Beyers N; Ayles H; Fidler S;
    N Engl J Med; 2019 Jul; 381(3):207-218. PubMed ID: 31314965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and Zambia.
    Vermund SH; Fidler SJ; Ayles H; Beyers N; Hayes RJ
    J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2(0 2):S221-7. PubMed ID: 23764639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of HIV prevention for high-risk groups at scale: an economic evaluation of the Avahan programme in south India.
    Vassall A; Pickles M; Chandrashekar S; Boily MC; Shetty G; Guinness L; Lowndes CM; Bradley J; Moses S; Alary M; ; Vickerman P
    Lancet Glob Health; 2014 Sep; 2(9):e531-e540. PubMed ID: 25304420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis.
    Smith JA; Sharma M; Levin C; Baeten JM; van Rooyen H; Celum C; Hallett TB; Barnabas RV
    Lancet HIV; 2015 Apr; 2(4):e159-68. PubMed ID: 25844394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV Care Cascade Among Adolescents in a "Test and Treat" Community-Based Intervention: HPTN 071 (PopART) for Youth Study.
    Shanaube K; Macleod D; Chaila MJ; Mackworth-Young C; Hoddinott G; Schaap A; Floyd S; Bock P; Hayes R; Fidler S; Ayles H
    J Adolesc Health; 2021 Apr; 68(4):719-727. PubMed ID: 33059959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards 90-90: Findings after two years of the HPTN 071 (PopART) cluster-randomized trial of a universal testing-and-treatment intervention in Zambia.
    Floyd S; Ayles H; Schaap A; Shanaube K; MacLeod D; Phiri M; Griffith S; Bock P; Beyers N; Fidler S; Hayes R;
    PLoS One; 2018; 13(8):e0197904. PubMed ID: 30096139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of self-reported tuberculosis treatment with community-wide universal testing and treatment for HIV and tuberculosis screening in Zambia and South Africa: A planned analysis of the HPTN 071 (PopART) cluster-randomised trial.
    Telisinghe L; Floyd S; MacLeod D; Schaap A; Dunbar R; Bwalya J; Bell-Mandla N; Piwowar-Manning E; Donnell D; Shaunaube K; Bock P; Fidler S; Hayes RJ; Ayles HM;
    PLoS Med; 2024 May; 21(5):e1004393. PubMed ID: 38820246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of point-of-care testing with task-shifting for HIV care in South Africa: a modelling study.
    Sharma M; Mudimu E; Simeon K; Bershteyn A; Dorward J; Violette LR; Akullian A; Abdool Karim SS; Celum C; Garrett N; Drain PK
    Lancet HIV; 2021 Apr; 8(4):e216-e224. PubMed ID: 33347810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.